COVID-19 vaccines for children are expected to include a monitoring period of at least two months after half the participants get the shots to ensure safety.The comments come as vaccine makers race to submit clinical data seeking regulatory approval for the use of their vaccinesin children below 12, as schools around the country begin to reopen for in-person learning.